Kisqali Femara Co-Pack 400 mg-2.5 mg Dose and Ofatumumab Intravenous
Determining the interaction of Kisqali Femara Co-Pack 400 mg-2.5 mg Dose and Ofatumumab Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: letrozole / ribociclib
Brand name: Kisqali Femara Co-Pack 200 mg-25 mg Dose, Kisqali Femara Co-Pack 400 mg-25 mg Dose, Kisqali Femara Co-Pack 600 mg-25 mg Dose
Synonyms: Kisqali Femara Co-Pack 200 mg-2.5 mg Dose, Kisqali Femara Co-Pack
Generic Name: ofatumumab
Brand name: Arzerra
Synonyms: Ofatumumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Kisqali Femara Co-Pack 400 mg-2.5 mg Dose-Ofev
- Kisqali Femara Co-Pack 400 mg-2.5 mg Dose-Off-Ezy Topical
- Kisqali Femara Co-Pack 400 mg-2.5 mg Dose-Ofirmev
- Kisqali Femara Co-Pack 400 mg-2.5 mg Dose-Ofloxacin
- Kisqali Femara Co-Pack 400 mg-2.5 mg Dose-Ofloxacin (Systemic)
- Kisqali Femara Co-Pack 400 mg-2.5 mg Dose-Oforta
- Ofatumumab Intravenous-Kisqali Femara Co-Pack 600 mg-2.5 mg Dose
- Ofatumumab Intravenous-Kitabis Pak
- Ofatumumab Intravenous-Kitabis Pak inhalation
- Ofatumumab Intravenous-Klofensaid II
- Ofatumumab Intravenous-Klonopin
- Ofatumumab Intravenous-Klonopin Wafer